The Swiss Trader

Long/short equity, growth, long-term horizon, biotech
The Swiss Trader
Long/short equity, growth, long-term horizon, biotech
Contributor since: 2012
Galena Removes Financing Risk
NeoStem Awarded $1.2 Million Grant For VSEL Development
An Exciting Week In Cell Therapy